These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 20665616)
41. Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cells. Chan A; Singh AJ; Northcote PT; Miller JH Invest New Drugs; 2016 Aug; 34(4):424-38. PubMed ID: 27155614 [TBL] [Abstract][Full Text] [Related]
42. Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration. Field JJ; Northcote PT; Paterson I; Altmann KH; Díaz JF; Miller JH Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467385 [TBL] [Abstract][Full Text] [Related]
43. Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity. Buey RM; Barasoain I; Jackson E; Meyer A; Giannakakou P; Paterson I; Mooberry S; Andreu JM; Díaz JF Chem Biol; 2005 Dec; 12(12):1269-79. PubMed ID: 16356844 [TBL] [Abstract][Full Text] [Related]
44. Non-taxoid site microtubule-stabilizing drugs work independently of tau overexpression in mouse N2a neuroblastoma cells. Das V; Miller JH Brain Res; 2012 Dec; 1489():121-32. PubMed ID: 23085090 [TBL] [Abstract][Full Text] [Related]
45. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin. Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277 [TBL] [Abstract][Full Text] [Related]
47. Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7. Chan A; Andreae PM; Northcote PT; Miller JH Invest New Drugs; 2011 Aug; 29(4):615-26. PubMed ID: 20169398 [TBL] [Abstract][Full Text] [Related]
48. Strategies for the synthesis of the novel antitumor agent peloruside A. Williams DR; Nag PP; Zorn N Curr Opin Drug Discov Devel; 2008 Mar; 11(2):251-71. PubMed ID: 18283613 [TBL] [Abstract][Full Text] [Related]
49. Synthesis of the C12-C19 fragment of (+)-peloruside A through a diastereomer-discriminating RCM reaction. Roulland E; Ermolenko MS Org Lett; 2005 May; 7(11):2225-8. PubMed ID: 15901175 [TBL] [Abstract][Full Text] [Related]
50. Cellular effects of the microtubule-targeting agent peloruside A in hypoxia-conditioned colorectal carcinoma cells. Řehulka J; Annadurai N; Frydrych I; Znojek P; Džubák P; Northcote P; Miller JH; Hajdúch M; Das V Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1833-1843. PubMed ID: 28366502 [TBL] [Abstract][Full Text] [Related]
51. GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol. Shintani Y; Tanaka T; Nozaki Y Cancer Chemother Pharmacol; 1997; 40(6):513-20. PubMed ID: 9332466 [TBL] [Abstract][Full Text] [Related]
52. Exploring the interaction of Peloruside-A with drug resistant αβII and αβIII tubulin isotypes in human ovarian carcinoma using a molecular modeling approach. Kumbhar BV; Bhandare VV J Biomol Struct Dyn; 2021 Apr; 39(6):1990-2002. PubMed ID: 32241247 [TBL] [Abstract][Full Text] [Related]
53. Delaying the onset of experimental autoimmune encephalomyelitis with the microtubule-stabilizing compounds, paclitaxel and Peloruside A. Crume KP; O'Sullivan D; Miller JH; Northcote PT; La Flamme AC J Leukoc Biol; 2009 Oct; 86(4):949-58. PubMed ID: 19654226 [TBL] [Abstract][Full Text] [Related]
54. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site. Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889 [TBL] [Abstract][Full Text] [Related]
55. Resistance to peloruside A and laulimalide: functional significance of acquired βI-tubulin mutations at sites important for drug-tubulin binding. Kanakkanthara A; Eras J; Northcote PT; Cabral F; Miller JH Curr Cancer Drug Targets; 2014; 14(1):79-90. PubMed ID: 24245693 [TBL] [Abstract][Full Text] [Related]
56. Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide. Miller JH; Singh AJ; Northcote PT Mar Drugs; 2010 Mar; 8(4):1059-79. PubMed ID: 20479967 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological activity of 7,8,9-trideoxy- and 7R desTHP-peloruside A. Wullschleger CW; Gertsch J; Altmann KH Chemistry; 2013 Sep; 19(39):13105-11. PubMed ID: 24038407 [TBL] [Abstract][Full Text] [Related]
60. Toward the synthesis of peloruside a: fragment synthesis and coupling studies. Paterson I; Di Francesco ME; Kühn T Org Lett; 2003 Feb; 5(4):599-602. PubMed ID: 12583779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]